Skip to main content
HomeResources

Resource Hub

A consolidated directory of advocacy organizations, pharmaceutical companies, epinephrine access programs, emergency guidance, and educational tools for the allergy and asthma community.

Advocacy Organizations
National & regional nonprofits supporting patients and driving policy — AAFA, FARE, AAIR, APFED, and more.
Epinephrine Devices & Research
FDA-approved epinephrine auto-injectors, nasal sprays, and the cutting-edge research shaping future care.
Low-Cost Epinephrine
Manufacturer copay cards, patient assistance programs, and generic options to access emergency epinephrine affordably.
Find an Allergist
Locate board-certified allergists and asthma specialists for diagnosis, treatment, and anaphylaxis action plans.
Emergency Hub
Anaphylaxis recognition, epinephrine usage guides, and emergency response steps for schools, restaurants, and home.
Training & Education
Staff training modules, certification resources, and anaphylaxis preparedness for schools, restaurants, and camps.
FARRP International Allergen Chart
University of Nebraska–Lincoln FARRP international regulatory chart comparing which food allergens must be labeled across 45+ countries worldwide.
FDA Food Code 2022
The FDA’s Food Code 2022 — the model that assists food control jurisdictions at all levels by providing them with a scientifically sound technical and legal basis for regulating the retail and food service segment of the industry, including allergen handling.
FDA Food Allergies
Official U.S. Food and Drug Administration resource on food allergen labeling, the top major allergens, recalls, and consumer guidance.
FDA Food Allergen Labeling Q&A (Federal Register)
FDA’s official Questions & Answers guidance on food allergens, including the food allergen labeling requirements of the Federal Food, Drug, and Cosmetic Act — the definitive federal interpretation of what must be declared on packaged food labels.
Virginia Food Regulations Update 2026
Effective September 10, 2026, Virginia updates its food establishment rules to align with the FDA Food Code, formally integrating sesame as a major allergen and requiring food service operators to disclose major allergens via menus, signs, or QR-code handouts.
AAAAI Food Allergy Overview
The American Academy of Allergy, Asthma & Immunology provides comprehensive information on food allergies, including causes, symptoms, diagnosis, and treatment options.
AAAAI Fire Ant Allergy
The American Academy of Allergy, Asthma & Immunology conditions library overview of fire ant allergy — symptoms, diagnosis, and treatment options for this serious stinging-insect allergy.
Omalizumab & Allergen Tolerance (Healio)
Healio Allergy/Asthma coverage of new findings that around one-third of patients tolerate full servings of their allergens with omalizumab (Xolair) — a significant advance in food allergy immunotherapy.
Tezspire Phase 3 EoE Win (FiercePharma)
FiercePharma coverage of Amgen and AstraZeneca’s anti-TSLP biologic Tezspire hitting all primary and key secondary endpoints in the phase 3 Crossing trial for eosinophilic esophagitis (EoE) — a potential new challenger to Sanofi/Regeneron’s Dupixent.
JAMA: Diagnosis of Celiac Disease
A JAMA Insights review comparing the latest guideline recommendations (ESsCD 2025, ACG 2023, ESPGHAN 2020) for serology-based versus biopsy-confirmed celiac disease diagnosis in adults and children, including when a no-biopsy diagnosis is appropriate.
Celiac Canada
The Canadian Celiac Association’s national resource hub — trusted information on celiac disease diagnosis, the gluten-free diet, safe food choices, and living well with celiac disease in Canada.
Gluten Free Globetrotter
A travel and lifestyle resource for the celiac and gluten-free community — tips for safe gluten-free dining and travel around the world, restaurant recommendations, and practical guidance for navigating new destinations without gluten.
FASI: Breast Milk Bacteria & Immune Defenses
A landmark Nature study led by Yale’s Dr. Noah Palm and supported by the Food Allergy Science Initiative finds that Bifidobacterium from dietary milk trains the infant immune system — a possible link between breast milk bacteria and increased immune defenses against food allergy.
AllergyEats
An allergy-friendly restaurant guide that helps you find restaurants that cater to individuals with food allergies, providing peace of mind when dining out.
FAME Program
Located at St. Louis Children’s Hospital, the Food Allergy Management & Education (FAME) program offers specialized care, education, and resources for children with food allergies and their families.
Kids with Food Allergies (KFA)
A division of the Asthma and Allergy Foundation of America (AAFA), KFA offers support, resources, and a community for families dealing with food allergies.
Parenting a Child with a Food Allergy
Kids with Food Allergies offers a comprehensive starter guide for parents, covering various aspects of parenting a child with a food allergy.
MenuTrinfo
A nutritional partner for food service businesses, offering expertise in nutrition, allergens, and Gluten-Free Certification to ensure safe dining experiences.
Food Allergy Pros
Food allergy training and consulting for food service businesses, schools, and camps — allergen management plans, staff certification, and dining-out safety guidance from food allergy professionals.
FAMS: Expert Recommendations for K–12
FARE’s Food Allergy Management in Schools (FAMS) — practical, evidence-based, actionable recommendations for school administrators, staff, and parents to keep K–12 students with food allergies safe, with a downloadable training slide deck in English and Spanish.
School Foodservice & Food Allergies
Guidance from the School Nutrition Association for schools and food service providers on safely managing food allergies in a school setting, ensuring the well-being of allergic students.
ATS Stock Albuterol Policy Statement
The American Thoracic Society’s September 2024 final policy statement on stock albuterol in schools — the clinical and policy framework supporting school-based emergency asthma rescue medication.
Asthma Peak Week (AAFA)
The Asthma and Allergy Foundation of America’s official guide to Asthma Peak Week — the third week of September when asthma attacks and ER visits spike due to back-to-school exposure, fall ragweed, and respiratory viruses. Learn the triggers and how to prepare.
September Asthma Peak & Fall Triggers (AAN)
The Allergy & Asthma Network’s podcast episode on spotting seasonal asthma triggers, preparing for the September Asthma Peak, and keeping asthma under control through the fall season.
Head Start History
The U.S. Administration for Children & Families Office of Head Start official history — tracing the program’s origins from 1965 through its evolution serving low-income children and families.
Head Start Services
The U.S. Administration for Children & Families overview of Head Start services — comprehensive early learning, health, nutrition, and family support for children from birth to age 5.
USDA WIC Program
The USDA Food and Nutrition Service official WIC (Special Supplemental Nutrition Program for Women, Infants, and Children) page — eligibility, benefits, and how WIC staff can help families with food allergies through personalized meal planning and one-on-one nutrition counseling.
WIC Food Packages & Food Allergy Prevention
FARE’s analysis of how changes to the USDA WIC (Women, Infants, and Children) food packages can promote food allergy prevention among infants — including broader safe substitution options for women and children with food allergies.
WIC & Early Allergen Introduction (PolicyLab)
Children’s Hospital of Philadelphia PolicyLab’s policy brief on how WIC revisions — including lowering the eligibility age for egg, wheat, soy, and peanut-based products from 1 year to 4–6 months — can support early allergen introduction and help prevent food allergies.

Pharmaceutical Companies & What They Do

The companies developing and manufacturing epinephrine devices, asthma biologics, food allergy immunotherapies, and treatments for allergic and eosinophilic diseases — with their key products and focus areas.

Viatris

Epinephrine auto-injectors

Key product(s): EpiPen / EpiPen Jr

Global healthcare company formed from the merger of Mylan and Upjohn. Manufacturer of the EpiPen, the most widely recognized epinephrine auto-injector.

Company website
Pfizer

Epinephrine distribution & biologics

Key product(s): EpiPen (distributor), Cibinqo (eczema)

Distributes EpiPen in the U.S. Also develops JAK inhibitors for atopic dermatitis and other allergic/inflammatory conditions.

Company website
kaléo

Epinephrine auto-injectors

Key product(s): Auvi-Q, AUVI-Q AFFORD

Specialty pharma focused on auto-injector innovation. Auvi-Q is the only epinephrine device with built-in voice instructions and auto-retracting needle.

Company website
Amphastar Pharmaceuticals

Epinephrine & asthma rescue

Key product(s): Symjepi, Primatene Mist, Baqsimi (glucagon)

Specialty pharma developing inhalation and injection products. Manufactures Symjepi epinephrine syringe and the OTC Primatene Mist asthma inhaler.

Company website
ARS Pharmaceuticals

Nasal epinephrine

Key product(s): neffy (epinephrine nasal spray)

Pioneered the first FDA-approved needle-free epinephrine nasal spray (neffy, approved 2024). Focuses on making emergency treatment more accessible.

Company website
Regeneron Pharmaceuticals

Biologics for allergic disease

Key product(s): Dupixent (dupilumab)

Co-developed Dupixent with Sanofi — a blockbuster biologic approved for atopic dermatitis, asthma, EoE, COPD, and chronic rhinosinusitis with nasal polyps.

Company website
Sanofi

Biologics & immunology

Key product(s): Dupixent (with Regeneron)

Global pharma leader in immunology and rare disease. Co-developer of Dupixent, the first biologic approved for eosinophilic esophagitis.

Company website
Genentech (Roche) / Novartis

Biologics for asthma & CSU

Key product(s): Xolair (omalizumab)

Xolair is approved for moderate-to-severe asthma, chronic spontaneous urticaria, and nasal polyps. In 2024, became the first medicine FDA-approved to reduce allergic reactions to multiple foods.

Company website
AstraZeneca

Asthma biologics & respiratory

Key product(s): Fasenra, Tezspire, Symbicort, Breztri

Leader in respiratory medicine. Fasenra targets eosinophilic asthma; Tezspire blocks TSLP for severe asthma. Broad portfolio of inhaled therapies.

Company website
GSK

Eosinophilic asthma & respiratory

Key product(s): Nucala (mepolizumab), Flovent, Trelegy

Nucala was the first anti-IL-5 biologic approved for severe eosinophilic asthma, also approved for EGPA, HES, and chronic rhinosinusitis with nasal polyps.

Company website
Teva Pharmaceuticals

Generic epinephrine & rescue inhalers

Key product(s): Generic epinephrine auto-injector, ProAir, AirDuo

Produced the first FDA-approved generic EpiPen. Also manufactures rescue inhalers (ProAir HFA) and combination inhalers for asthma.

Company website
DBV Technologies

Epicutaneous immunotherapy (EPIT)

Key product(s): Viaskin (peanut patch pipeline)

Biotech developing Viaskin — a skin patch delivering peanut protein for desensitization. Focused on needle-free, non-oral immunotherapy for food allergies.

Company website
Stallergenes Greer

Allergen immunotherapy

Key product(s): Sublingual & subcutaneous immunotherapy

Global leader in allergy immunotherapy, offering both subcutaneous (SCIT) and sublingual (SLIT) allergy drops/tablets for environmental allergies.

Company website
Allakos

Eosinophilic & mast cell disease

Key product(s): Lirentelimab (AK002 pipeline)

Clinical-stage biotech developing therapeutics for eosinophilic and mast cell mediated diseases including EoE, EGID, and chronic urticaria.

Company website
HAL Allergy

Allergy immunotherapy

Key product(s): PURETHAL (SCIT), ORALVAC (SLIT)

European biopharma specializing in allergy immunotherapy for respiratory and venom allergies. Developing modified allergens for safer desensitization.

Company website
Aimmune Therapeutics (Nestlé Health Science)

Food allergy immunotherapy

Key product(s): Palforzia (peanut OIT)

Developed Palforzia — the first FDA-approved treatment for peanut allergy (2020). Nestlé discontinued Palforzia in 2024, but research in oral immunotherapy continues.

Company website
Aquestive Therapeutics

Sublingual film drug delivery

Key product(s): Anaphylm (AQST-109 sublingual epinephrine film)

Specialty pharma leveraging its PharmFilm® technology to develop Anaphylm™ (dibutepinephrine) — the first orally delivered sublingual film formulation of epinephrine, in clinical development for the emergency treatment of anaphylaxis. FDA accepted the New Drug Application in 2025.

Company website

While we strive for accuracy, information may change over time. Always double-check and verify against official sources before relying on it.

PolicyPantry

Connecting America to Allergy Knowledge, Laws, and Care.

Empowering advocates for allergy, asthma & anaphylaxis rights nationwide.

Follow @policypantry

Educational Disclaimer: The information on this platform is provided for general educational and informational purposes only. It is not medical advice and does not replace professional medical consultation, diagnosis, or treatment. Always seek the guidance of a qualified healthcare professional with any questions about a medical condition. If you are experiencing a medical emergency, call 911 immediately. While we strive for accuracy, please double-check and verify any information found here against official sources before relying on it.

Policy Pantry™ is a health policy technology platform empowering communities through legislation, advocacy, and innovation.

© 2026 Policy Pantry LLC. All Rights Reserved.